DELCF logo

Delic Holdings Corp. (DELCF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

DELCF representa a Delic Holdings Corp., una empresa del sector Communication Services con un precio de $ (capitalización de mercado 0). La acción obtiene una puntuación de 57/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 16 mar 2026
Puntuación de IA de 57/100

Delic Holdings Corp. (DELCF) Perfil de Medios y Comunicaciones

CEOKevin Nicholson
Empleados116
Sede CentralVancouver, CA
Año de la oferta pública inicial (OPI)2021

Delic Holdings Corp. is a diversified company in the psychedelic wellness space, offering media platforms like Reality Sandwich and Meet Delic events, alongside ketamine infusion clinics. The company focuses on creating content and providing treatments within the emerging psychedelic medicine market, primarily in the United States and Canada.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 16 mar 2026

Tesis de Inversión

Delic Holdings Corp. presents a unique investment opportunity within the nascent psychedelic wellness sector. The company's diversified approach, encompassing media, education, and clinical treatments, positions it to capitalize on the growing interest in psychedelic therapies. Key value drivers include the expansion of its ketamine infusion clinic network and the growth of its online education platform, Reality Sandwich. The company's gross margin is 100.0%. Potential catalysts include favorable regulatory changes regarding psychedelic therapies and increasing public acceptance of these treatments. However, investors should be aware of the risks associated with operating in a highly regulated and evolving industry, as well as the company's negative profit margin of -565.9%.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Delic Holdings Corp. operates in the emerging psychedelic wellness market, focusing on media, education, and clinical treatments.
  • The company's media platforms, including Reality Sandwich and Meet Delic, aim to foster public discourse and education around psychedelics.
  • Delic owns and operates ketamine infusion clinics, providing therapeutic treatments in the United States and Canada.
  • The company's gross margin is 100.0%, indicating strong potential for profitability as the market matures.
  • Delic's market capitalization is $0.00B, reflecting its early-stage growth and potential for future expansion.

Competidores y Pares

Fortalezas

  • Diversified business model encompassing media, education, and clinical treatments.
  • Established media platforms with a significant online presence.
  • Ownership of ketamine infusion clinics provides a direct revenue stream.
  • Focus on research and development for cannabis and psychedelics.

Debilidades

  • Negative profit margin indicates financial challenges.
  • Small market capitalization and limited trading volume on the OTC market.
  • Reliance on a nascent and evolving regulatory environment.
  • Limited brand recognition compared to larger players in the wellness industry.

Catalizadores

  • Ongoing: Increasing public awareness and acceptance of psychedelic therapies.
  • Upcoming: Potential regulatory changes regarding the use of psychedelics for mental health treatment.
  • Ongoing: Expansion of ketamine infusion clinic network across North America.
  • Ongoing: Growth of online education platform through content expansion and marketing efforts.

Riesgos

  • Potential: Unfavorable regulatory changes regarding psychedelic therapies.
  • Ongoing: Increased competition from larger and more established players in the wellness industry.
  • Potential: Negative public perception or safety concerns regarding psychedelics.
  • Ongoing: Economic downturn impacting consumer spending on wellness services.
  • Ongoing: Negative profit margin indicates financial challenges.

Oportunidades de crecimiento

  • Expansion of Ketamine Infusion Clinics: Delic has the opportunity to expand its network of ketamine infusion clinics across North America. The market for ketamine treatments is growing, driven by its effectiveness in treating depression and other mental health conditions. By strategically opening new clinics in underserved areas, Delic can increase its revenue and market share. The timeline for expansion is ongoing, with potential for significant growth over the next 3-5 years. This expansion can establish Delic as a leading provider of psychedelic-assisted therapies.
  • Growth of Online Education Platform: Reality Sandwich, Delic's online education platform, has the potential to become a leading resource for information on psychedelics. By expanding its content library and marketing efforts, Delic can attract a larger audience and generate revenue through subscriptions and advertising. The market for online education is vast and growing, with increasing interest in alternative therapies and wellness practices. The timeline for growth is ongoing, with potential for significant expansion over the next 2-3 years. This can establish Delic as a leading provider of psychedelic education.
  • Development of Intellectual Property: Delic's focus on research and development for cannabis and psychedelics presents a significant growth opportunity. By developing novel formulations and treatment protocols, the company can create valuable intellectual property that can be licensed or commercialized. The market for psychedelic-based pharmaceuticals is expected to grow rapidly in the coming years, driven by increasing regulatory acceptance and clinical research. The timeline for development is ongoing, with potential for significant breakthroughs over the next 3-5 years. This can establish Delic as a leading innovator in the psychedelic space.
  • Strategic Partnerships and Acquisitions: Delic can pursue strategic partnerships and acquisitions to expand its reach and capabilities. By partnering with other companies in the psychedelic wellness space, such as research institutions or therapy providers, Delic can gain access to new technologies, markets, and expertise. The market for mergers and acquisitions in the psychedelic industry is expected to increase in the coming years, as companies seek to consolidate their positions. The timeline for partnerships and acquisitions is ongoing, with potential for significant deals over the next 1-2 years. This can accelerate Delic's growth and market leadership.
  • Increased Public Awareness and Acceptance: As public awareness and acceptance of psychedelics increase, Delic is well-positioned to benefit from the growing demand for psychedelic therapies and education. The company's media platforms and educational resources can play a key role in shaping public perception and promoting responsible use of psychedelics. The timeline for increased awareness and acceptance is ongoing, with potential for significant progress over the next 3-5 years. This can create a more favorable regulatory environment and drive increased investment in the psychedelic industry.

Oportunidades

  • Expansion of ketamine infusion clinic network across North America.
  • Growth of online education platform through content expansion and marketing efforts.
  • Development of intellectual property for novel psychedelic therapies.
  • Strategic partnerships and acquisitions to expand reach and capabilities.

Amenazas

  • Unfavorable regulatory changes regarding psychedelic therapies.
  • Increased competition from larger and more established players.
  • Negative public perception or safety concerns regarding psychedelics.
  • Economic downturn impacting consumer spending on wellness services.

Ventajas competitivas

  • Diversified business model across media, education, and clinical treatments reduces reliance on any single revenue stream.
  • Established media platforms like Reality Sandwich provide a strong brand presence and audience reach.
  • Ownership of ketamine infusion clinics offers a direct channel for delivering therapeutic treatments.

Acerca de DELCF

Delic Holdings Corp., headquartered in Vancouver, Canada, is a multifaceted company operating within the rapidly evolving psychedelic wellness industry. Founded with the vision of fostering a comprehensive ecosystem around psychedelic culture and therapeutic applications, Delic has established a diverse portfolio of assets. These include media platforms, educational resources, and clinical treatment centers. The company's media arm includes 'The Delic,' a platform for public discourse on psychedelic culture; 'Meet Delic,' an event organizer promoting safety, harm reduction, and mental health discussions; 'Reality Sandwich,' an online education platform with approximately 10,000 pieces of content; and 'Delic Radio,' a podcast exploring news, science, culture, and policy related to psychedelics. Delic also focuses on intellectual property development for cannabis and psychedelics through research and development initiatives. Furthermore, Delic operates two ketamine infusion treatment clinics and owns thirteen ketamine infusion treatment clinics, offering therapeutic interventions. This combination of media, education, and clinical services positions Delic as a notable player in the emerging psychedelic medicine market in the United States and Canada.

Qué hacen

  • Operates 'The Delic', a creative platform for psychedelic culture discourse.
  • Organizes 'Meet Delic' events to promote safety, harm reduction, and mental health discussions related to psychedelics.
  • Manages 'Reality Sandwich', an online education platform with psychedelic guides, news, and culture content.
  • Produces 'Delic Radio', a podcast discussing psychedelic-related topics with experts.
  • Focuses on developing intellectual property for cannabis and psychedelics through research and development.
  • Owns and operates two ketamine infusion treatment clinics.
  • Owns thirteen ketamine infusion treatment clinics.

Modelo de Negocio

  • Generates revenue through ketamine infusion treatments at its clinics.
  • Monetizes its media platforms through advertising, sponsorships, and event ticket sales.
  • Explores revenue opportunities through licensing or commercialization of intellectual property developed through R&D.

Contexto de la Industria

Delic Holdings Corp. operates within the rapidly expanding psychedelic wellness industry, a sector gaining increasing attention for its potential therapeutic applications. The market is driven by growing awareness of mental health issues and the limitations of traditional treatments. While still in its early stages, the industry is attracting significant investment and research, with companies exploring the use of psychedelics for conditions such as depression, anxiety, and PTSD. Delic's diversified approach, combining media, education, and clinical services, positions it to capitalize on this evolving landscape. Competitors are emerging across various segments, from drug development to therapy clinics.

Clientes Clave

  • Individuals seeking ketamine infusion treatments for mental health conditions.
  • Individuals interested in learning about psychedelic culture and therapies.
  • Professionals and researchers in the cannabis and psychedelic industries.
Confianza de la IA: 79% Actualizado: 16 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Delic Holdings Corp. (DELCF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para DELCF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para DELCF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para DELCF.

MoonshotScore

57/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de DELCF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Kevin Nicholson

CEO

Kevin Nicholson is the CEO of Delic Holdings Corp. His background includes experience in managing and scaling businesses within the emerging wellness sector. He has a track record of building and leading teams, developing strategic partnerships, and driving revenue growth. Nicholson's expertise lies in identifying market opportunities and executing innovative business strategies. He is focused on positioning Delic as a leader in the psychedelic wellness industry.

Historial: Under Kevin Nicholson's leadership, Delic Holdings Corp. has expanded its media platforms, increased its clinic network, and advanced its research and development efforts. He has overseen the company's strategic acquisitions and partnerships, contributing to its growth and market presence. Nicholson has also focused on building a strong team and fostering a culture of innovation within the company.

Información del mercado OTC de DELCF

The OTC Other tier represents the lowest tier of the OTC market, indicating that Delic Holdings Corp. may not meet the minimum financial standards required for higher tiers like OTCQB or OTCQX. Companies in this tier may have limited financial disclosure and may not be subject to the same regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries a higher degree of risk due to the potential for limited information and liquidity.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: As an OTC stock, DELCF likely experiences lower trading volume and wider bid-ask spreads compared to stocks listed on major exchanges. This can make it more difficult to buy or sell shares quickly and efficiently, potentially leading to price volatility. Investors should be aware of the liquidity risks associated with trading DELCF.
Factores de riesgo OTC:
  • Limited financial disclosure increases the risk of investing in DELCF.
  • Lower trading volume and wider bid-ask spreads can lead to price volatility.
  • The OTC Other tier indicates a higher degree of risk compared to major exchanges.
  • The regulatory oversight is less stringent for OTC-listed companies.
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's growth potential and market opportunities.
  • Understand the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Señales de legitimidad:
  • The company has established media platforms and ketamine infusion clinics.
  • The company is focused on research and development for cannabis and psychedelics.
  • The company has a management team with experience in the wellness sector.

DELCF Preguntas Frecuentes sobre Acciones de Communication Services

¿Cuáles son los factores clave para evaluar DELCF?

Delic Holdings Corp. (DELCF) actualmente tiene una puntuación IA de 57/100, indicando puntuación moderada. Fortaleza clave: Diversified business model encompassing media, education, and clinical treatments.. Riesgo principal a monitorear: Potential: Unfavorable regulatory changes regarding psychedelic therapies.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de DELCF?

DELCF actualmente puntúa 57/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de DELCF?

Los precios de DELCF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre DELCF?

La cobertura de analistas para DELCF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en DELCF?

Las categorías de riesgo para DELCF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Potential: Unfavorable regulatory changes regarding psychedelic therapies.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de DELCF?

La relación P/E para DELCF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está DELCF sobrevalorada o infravalorada?

Determinar si Delic Holdings Corp. (DELCF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de DELCF?

Delic Holdings Corp. (DELCF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available for OTC-listed companies.
  • Analyst ratings may not be available for DELCF due to its small market capitalization.
Fuentes de datos

Popular Stocks